Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Firouzeh Korangy

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|June 6, 2022
Plasticity of Innate Lymphoid Cells in CancerBernd Heinrich, Firouzeh Korangy
Hepatology (Baltimore, Md.)|June 24, 2014
Intrahepatic landscape of regulatory T-cell subsets in chronically HCV-infected patients with cirrhosis and HCCXiao-Fan Wang, Firouzeh Korangy
Journal of Hepatology|July 13, 2010
Radiofrequency ablation for the treatment of HCC--maybe much more than simple tumor destruction?Tim F Greten, Firouzeh Korangy
Gut|November 3, 2016
Shall we blame CD4 T cells for everything?Tim F Greten, Firouzeh Korangy
Gut|October 26, 2017
CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCCTim F Greten, Firouzeh Korangy
Cellular and Molecular Life Sciences : CMLS|October 3, 2014
Immunogenicity of necrotic cell deathJaba Gamrekelashvili, Tim F Greten, Firouzeh Korangy
Digestive Diseases (Basel, Switzerland)|October 31, 2012
Cellular immune suppressor mechanisms in patients with hepatocellular carcinomaFei Zhao, Firouzeh Korangy, Tim F Greten
Hepatology (Baltimore, Md.)|April 2, 2022
Innate lymphoid cells at the crossroads of innate and adaptive immunityFirouzeh Korangy, Bernd Heinrich, Tim F Greten
Nature Reviews. Cancer|April 20, 2023
Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunityBenjamin Ruf, Tim F Greten, Firouzeh Korangy
Immunological Investigations|September 29, 2012
Immune suppression: the hallmark of myeloid derived suppressor cellsLydia A Haile, Tim F Greten, Firouzeh Korangy
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|June 6, 2022
Plasticity of Innate Lymphoid Cells in CancerBernd Heinrich, Firouzeh Korangy
Hepatology (Baltimore, Md.)|June 24, 2014
Intrahepatic landscape of regulatory T-cell subsets in chronically HCV-infected patients with cirrhosis and HCCXiao-Fan Wang, Firouzeh Korangy
Journal of Hepatology|July 13, 2010
Radiofrequency ablation for the treatment of HCC--maybe much more than simple tumor destruction?Tim F Greten, Firouzeh Korangy
Gut|November 3, 2016
Shall we blame CD4 T cells for everything?Tim F Greten, Firouzeh Korangy
Gut|October 26, 2017
CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCCTim F Greten, Firouzeh Korangy
Cellular and Molecular Life Sciences : CMLS|October 3, 2014
Immunogenicity of necrotic cell deathJaba Gamrekelashvili, Tim F Greten, Firouzeh Korangy
Digestive Diseases (Basel, Switzerland)|October 31, 2012
Cellular immune suppressor mechanisms in patients with hepatocellular carcinomaFei Zhao, Firouzeh Korangy, Tim F Greten
Hepatology (Baltimore, Md.)|April 2, 2022
Innate lymphoid cells at the crossroads of innate and adaptive immunityFirouzeh Korangy, Bernd Heinrich, Tim F Greten
Nature Reviews. Cancer|April 20, 2023
Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunityBenjamin Ruf, Tim F Greten, Firouzeh Korangy
Immunological Investigations|September 29, 2012
Immune suppression: the hallmark of myeloid derived suppressor cellsLydia A Haile, Tim F Greten, Firouzeh Korangy
Pageof 8